2023 annual financial data

ProQR Therapeutics 2023 Net margin

Direct answer

Net margin was -431.67%.

Operating income was -31.86M EUR and net income was -28.12M EUR.
Operating cash flow was 21.55M EUR.

Get free ProQR Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6.51M EUR
Operating income
-31.86M EUR
Net income
-28.12M EUR
Operating cash flow
21.55M EUR